Ulodesine

DB12353InvestigationalSmall molecule

Ulodesine has been used in trials studying the treatment of Gout, Arthritis, Hyperuricemia, and Joint Disease.

Mechanism: Pharmacologically active on Purine nucleoside phosphorylase
Curator reviewed
Formula / weight: C₁₂H₁₆N₄O₃ · 264.285 g/mol (avg)
Also known as: 4H-PYRROLO(3,2-D)PYRIMIDIN-4-ONE, 1,5-DIHYDRO-7-(((3R,4R)-3-HYDROXY-4-(HYDROXYMETHYL)-1-PYRROLIDINYL)METHYL)- · 7-(((3R,4R)-3-HYDROXY-4-(HYDROXYMETHYL)PYRROLIDIN-1-YL)METHYL(-1,5-DIHYDRO-4H-PYRROLO(3,2-D)PYRIMIDIN-4-ONE · 7-(((3R,4R)-3-HYDROXY-4-(HYDROXYMETHYL)PYRROLIDIN-1-YL)METHYL)-3,5-DIHYDRO-4H-PYRROLO(3,2-D)PYRIMIDIN-4-ONE · DADME-IMMUCILLIN H
Code names: BCX-4208 · LR-09 · R-3421

Resolves to

Compound

Structure

InChIKeyAFNHHLILYQEHKK-BDAKNGLRSA-NSMILESOC[C@H]1CN(CC2=CNC3=C2N=CNC3=O)C[C@@H]1O

Targets

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ulodesine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.